🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The HER2 protein is becoming a crucial target not only in breast cancer but also in other tumor subtypes. 🔬✨ Super experts discuss the role of IHC in #lungcancer and #ovariancancer! Christian Rolfo RolfoLab #HER2 #IHC #Targettherapy

Honored to be among the winners of the #TexasLung25 Poster Competition! 🎉 Grateful for the opportunity to share my research and contribute to the future of #lungcancer. See you in Austin!🔬 Christian Rolfo Umberto Malapelle RolfoLab The James Università di Genova

2025 ISLB Annual Congress, will take place in Orlando, Florida, November 1-3, 2025. This is an extraordinary gathering of scientists, clinicians, industry leaders, and innovators, all united by a shared passion for advancing liquid biopsy 2025.islb.info

Online Now: Pan-cancer human brain metastases atlas at single-cell resolution dlvr.it/TK6FLl

Day 3 at #TexasLung25 diving into diagnostics, #MRD, and #LiquidBiopsy with an outstanding faculty! 🩸🔬 Learning from the best: Christian Rolfo David Gandara Wade Iams @TheJamesOSU RolfoLab TLC Conference Exciting discussions shaping the future of #lungcancer testing! 📚

Pelotonia registration is in full swing, so it’s a great time for my colleagues at the The James, and everyone in the Ohio State community, to sign up for Team Buckeye. cancer.osu.edu/for-donors-and…

Visit at #AACR25 the poster by Dr. Eswar Shankar on “Synergistic Inhibition of TNBC via EZH2 inhibition and D1 Receptor Agonism” The James Ohio State Medical Oncology The Ohio State University College of Medicine Christian Rolfo #DanielStover AACR

Our team RolfoLab at #AACR25! Congrats Drs Eswar Shankar and Diego de Miguel Perez for your great job! AACR Ohio State Medical Oncology Ohio State Medical Oncology Roberto Borea, MD Christian Rolfo

Visit Eswar Shankar at #AACR25 to learn more about synergistic inhibition of TNBC via EZH2 inhibition & D1 receptor agonism RolfoLab

Division director Christian Rolfo, MD, PhD, explains his Ohio State Medical Oncology team’s comprehensive approach to the treatment and study of several cancers.

From The James to The Hope Foundation for Cancer Research for a Lecture! Lucky to have such an internationally recognized mentor! 🗺️Christian Rolfo RolfoLab

picture day at RolfoLab !! Great team! Website available soon! The James Ohio State Medical Oncology The Ohio State University College of Medicine Roberto Borea, MD Christian Rolfo Diego de Miguel Perez International Society of Liquid Biopsy

Glad and honored to be part of your team, Christian Rolfo! ☺️🦾

Here’s a rundown of some of the recent awards and accomplishments from our amazing team at the The James. cancer.osu.edu/news/april-202…

The James is growing more than ever with brilliant physicians and pioneering scientists! I am lucky to be part of it! Christian Rolfo Ohio State Medical Oncology RolfoLab

Expert brings global track record of cancer discovery to Ohio State health.osu.edu/health/cancer/… via The Ohio State University Wexner Medical Center Christian Rolfo RolfoLab

Christian Rolfo presenting at Lung-MAP Annual Update at #ASCO25 the S1900J trial for patients with #NSCLC and #METamplification as primary driver treated with Amivantab sc. SWOG Cancer Research Network Foundation for the National Institutes of Health Ohio State Medical Oncology The James ASCO Shirish Gadgeel David Gandara RolfoLab

The James reception at #ASCO25 with Christian Rolfo and Kimryn Rathmell 🔥 The OSU family is growing strong with a great vision.. the best is yet to start! The Ohio State University Wexner Medical Center RolfoLab

🚨Our paper in Clinical Cancer Research is out “Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC : Analyses from the Phase II VISION trial of Tepotinib” important #liquidbiopsy application METCrusaders The James Ohio State Medical Oncology RolfoLab AACR International Society of Liquid Biopsy

World class lung cancer screening is ready to hit the road in Ohio, as Jasleen Pannu, MBBS, and colleagues cut the ribbon on our new state of the art mobile unit.